Conclusion: The vast majority of the results cast doubt on previous assumptions claiming that brassica plants have antithyroid effects in humans. Instead, they indicate that including brassica vegetables in the daily diet, particularly when accompanied by adequate iodine intake, poses no adverse effects on thyroid function.
PubMed 38612798 ↗Indole-3-Carbinol
The short answer. There isn't much data on Indole-3-Carbinol yet — 10 mentions, 5 with a clear outcome — so treat these numbers as anecdotal. It is most often used for hormones: 100% of 5 reports say that improved. It is well studied — 6 meta-analyses on PubMed.
From 10 mentions in total — the rest didn't say how it went and aren't counted.
What Indole-3-Carbinol does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 6 meta-analyses on PubMed ↗ · 14 randomized trials ↗
Conclusion: Topical treatment (imiquimod or cidofovir) may effectively treat about half of uVIN cases after a 16-week course of treatment, but the evidence on whether this effect is sustained is limited. Factors predicting response to treatment are not clear, but small lesions may be more likely to respond. The relative risk of progression to vulval cancer is uncertain. However, imiquimod and cidofovir appear to be relatively well tolerated and may be favoured by some women over primary surgical treatment.There is currently no evidence on how medical treatment compares with surgical treatment. Women who u
PubMed 26728940 ↗Conclusion: Imiquimod appears to be effective, but its safety needs further examination. Its use is associated with side effects which are tolerable, but more extensive data on adverse effects are required. Long term follow-up should be mandatory in view of the known progression of high grade VIN to invasive disease. Alternative medical interventions, such as cidofovir, should be explored.
PubMed 21491403 ↗Conclusion: Topical imiquimod appears to be a safe and effective treatment for high-grade VIN (uVIN), even though local side-effects may necessitate dose reductions. However, longer term follow-up data are needed to corroborate the limited evidence that response to treatment is sustained, and to assess any effect on progression to vulval cancer. Available evidence suggests that topical cidofovir may be a good alternative to imiquimod; however, more evidence is needed, particularly regarding the relative effectiveness on longer term response and progression. We await the longer-term response data and the r
PubMed 26284429 ↗13 human trials on ClinicalTrials.gov test Indole-3-Carbinol — 7 completed, 1 recruiting now. See all on ClinicalTrials.gov ↗
- Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet · Environmental Exposure · 2024
- Nutritional Intervention and DNA Damage of Patients With HBOC · HBOC Syndrome, DNA Damage · 2022
- Trial of Indole-3-Carbinol and Silibinin · Smoking · 2021
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
- Source of (an) antioxidant(s)/Provides (an) antioxidant(s).
- Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
- Helps to support/promote healthy estrogen metabolism/balance.
Required cautions: Ask a health care practitioner before use to exclude the diagnosis of a serious cause of hormonal imbalance. Ask a health care practitioner before use if you are taking medications or natural health products. Ask a health care practitioner before use if you are attempting to conceive.
No health claim for Indole-3-Carbinol is authorised in the EU.
2 proposed claims were rejected, usually because EFSA found the evidence insufficient (example ↗).
NIH has funded 14 research projects with Indole-3-Carbinol in the title, $6,609,043 in total (1992–2019). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Indole-3-carbinol is good for reducing estrogen metabolism, which I at least gives you a similar feeling to increased test, if not actually upping it.”
“I personally like eating a ton of brocolli/cabbage (for the Indole-3-carbinol content)...with the above two in my diet at least twice a day the puffiness is greatly reduced”
“I use resveratrol, but only because I work for a supplement company...Other than that I just eat lots of broccoli for the I3C”
Top discussions (5)
- Today I release a 2.5-hour follow-up to my sulforaphane video: an in-depth conversation with renown sulforaphane researcher and director of the Cullman Chemoprotection Center at Johns Hopkins, Dr. Jed Fahey. ↗
- What supplements actually significantly increase testosterone? ↗
- I "examined" the primary ingredients in the 4 best selling Testosterone Supplements on Amazon. Pretty much all of them are bogus. ↗
- Increased TMAO levels are associated with increased risk for heart disease and cancers. Here is how to reduce your TMAO. ↗
- Supplement for men to help Increase Testosterone/Lower Estrogen? ↗
Other options for hormones
Sources
- User reports: 10 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- NIH RePORTER ↗
- Health Canada ↗
- EU health-claims register ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate